Grail spinoff by Illumina should end disastrous merger attempt STAT STAT | Makemetechie.com Summary
News Summary
- Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work..
- Get unlimited access to award-winning journalism and exclusive events..
- Senior Writer, Medicine, Editorial Director of EventsMatthew Herper covers medical innovation — both its promise and its perils.biotechnologycancerdiagnosticsgeneticsSTAT+ Exciting news!.
- Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads..
- To submit a correction request, please visit our Contact Us page.advertisement.
- Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020..
Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multicancer screening test, which it bought over the objections of regulators in th [+900 chars]